|

Ad5.F35-hGUCY2C-PADRE vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Ad5/F35-hGCC-PADRE, Adenovirus 5/F35-HGCC-PADRE

Pipeline

Phase 1: 1

Top Sponsors

  • Thomas Jefferson University1

Indications

  • Small Bowel Adenocarcinoma1
  • Colorectal Cancer1
  • Cancer1

Philadelphia, Pennsylvania1 trial

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Sidney Kimmel Cancer Center at Thomas Jefferson University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.